产品编号 :
Cas No. :
CAS No. |
2713577-16-1 |
|---|---|
中文名称 |
SKLB-197(该名称为研发代号/缩写,非IUPAC系统命名;需提供完整英文系统命名或结构信息(如SMILES/InChI)以生成符合CCS的中文系统名) |
英文名称 |
SKLB-197 |
别名 |
Quinazoline, 2-(1H-indol-4-yl)-4-[(3R)-3-methyl-4-morpholinyl]-6-(1-methyl-1H-pyrazol-5-yl)- |
标准英文名 |
(R)-4-(2-(1H-indol-4-yl)-6-(1-methyl-1H-pyrazol-5-yl)quinazolin-4-yl)-3-methylmorpholine |
分子式 |
C25H24N6O |
分子量 |
424.51 |
精确分子量 |
424.20 |
SMILES |
C[C@H]1N(C2=C3C=C(C4=CC=NN4C)C=CC3=NC(C5=CC=CC6=C5C=CN6)=N2)CCOC1 |
标准SMILES |
CN1N=CC=C1C1=CC2=C(N=C(N=C2C=C1)C1=CC=CC2NC=CC=21)N1CCOC[C@H]1C |
用途 |
SKLB-197 exhibits potent anti-tumor activity against ATM-deficient tumors both in vitro and in vivo; it is a potent and selective ATR inhibitor with an IC50 of 0.013 μM, showing minimal or no activity against a panel of 402 other protein kinases. |
InChIKey |
FCNFJRRMUAOHKI-MRXNPFEDSA-N |
|
|
评论 |
|---|